Evidence map›Paper›PMID 27530409›Full record

ArticleClinical rheumatology2016

Gastrointestinal comorbidities in patients with psoriatic arthritis.

Ariel Zohar, Arnon Dov Cohen, Haim Bitterman, Ilan Feldhamer, Sari Greenberg-Dotan, Idit Lavi, Doron Comanesther, Erez Batat, Devy Zisman

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.Advances in rheumatology (London, England) · 2021
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Immune responses and therapeutic options in psoriasis.Cellular and molecular life sciences : CMLS · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ariel ZoharThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Arnon Dov CohenCentral Headquarters, Clalit Health Services, Tel Aviv, Israel.
Haim BittermanThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Ilan FeldhamerCentral Headquarters, Clalit Health Services, Tel Aviv, Israel.
Sari Greenberg-DotanCentral Headquarters, Clalit Health Services, Tel Aviv, Israel.
Idit LaviDepartment of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Doron ComanestherCentral Headquarters, Clalit Health Services, Tel Aviv, Israel.
Erez BatatCentral Headquarters, Clalit Health Services, Tel Aviv, Israel.
Devy ZismanThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. devyzisman@gmail.com.
Clalit Health Services · ILCarmel Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comorbidities associated with psoriatic arthritis (PsA) include cardiovascular diseases, diabetes mellitus, and obesity. This study evaluated the association between PsA and common gastrointestinal (GI) diseases. A retrospective study was performed in Israel's largest health care provider database between 2002 and 2013. 3161 PsA patients were matched for age and sex with 31610 randomly selected patients. We searched these patients' records for the presence of peptic ulcer disease (PUD), reflux esophagitis, Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS) and celiac disease. T-test was used to compare continuous variables and a Chi-square test was used for categorical variables. Multivariate logistic regression models were used to assess the association between PsA and GI comorbidities. PsA was associated with Crohn's disease (OR 2.4, 95 %CI: 1.75-3.32, p < 0.0001), ulcerative colitis (OR 2.1, 95 %CI: 1.33-3.26, p = 0.001), reflux esophagitis (OR 1.6, 95 %CI: 1.44-1.78, p < 0.0001), PUD (OR 1.5, 95 %CI: 1.31-1.63, p < 0.0001) and IBS (OR 1.4, 95 %CI: 1.01-1.86, p = 0.045). After controlling for known risk factors, the association remained significant between PsA and Crohn's disease (OR 2.2, 95 %CI: 1.59-3.03, p < 0.0001), ulcerative colitis (OR 1.9, 95 %CI: 1.21-3.00, p = 0.005), reflux esophagitis (OR 1.5, 95 %CI: 1.31-1.63, p < 0.0001), and PUD (OR 1.3, 95 %CI: 1.12-1.47, p < 0.0001). No significant association was found between PsA and celiac disease. In the current study PsA was associated with gastrointestinal morbidities including Crohn's disease, ulcerative colitis, PUD and IBS. Physicians treating patients with PsA should be aware of these associations.

Indexed as

AdultAgedArthritis, PsoriaticCeliac DiseaseColitis, UlcerativeComorbidityCrohn DiseaseDatabases, FactualEsophagitisFemaleHumansIrritable Bowel SyndromeIsraelMaleMiddle AgedPrevalenceGastrointestinal diseasesPsoriatic arthritis.Spondyloarthritis

Identifiers

PMID27530409
OpenAlexW2515675992

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.